Posted on 3/7/21
David Nevins Interviews Dr. Matthew Frieman, Associate Professor, University of Maryland School of Medicine
Dr. Frieman’s overall research goal is to create therapeutic interventions for viruses of public health concern by developing
Posted on 2/26/21
Immunic Reports Year End 2020 Financial Results
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced . . .
Posted on 2/26/21
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced its results today for the fourth quarter and full year ended December 31, 2020."We are extremely proud of the . . .
Posted on 2/26/21
Relivant to Acquire Silicon Therapeutics for $450 Million
Roivant Sciences today announced it has entered into a definitive agreement to acquire Silicon Therapeutics for $450 million in Roivant equity, with additional potential regulatory and . . .
Posted on 2/25/21
Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for . . .
Posted on 2/25/21
Provention Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today reported financial results for the fourth quarter and full year . . .
Posted on 2/25/21
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today reports financial . . .
Posted on 2/25/21
Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results
PARSIPPANY, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health . . .
Posted on 2/25/21
MTBC Reports Record Full Year 2020 Results
SOMERSET, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced . . .
Posted on 2/25/21
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2020 Financial Results And Provides Corporate Update
NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central . . .
Posted on 2/25/21
DLA Piper Advises Truvian Sciences in Oversubscribed $105 Million Series C
DLA Piper represented Truvian Sciences in its recent oversubscribed US$105 million Series C financing. The round was led by TYH Ventures, Glen Tullman of 7wireVentures and . . .
Posted on 2/25/21
Merck to Acquire Pandion Therapeutics
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Pandion Therapeutics, Inc. (Nasdaq: PAND) today announced that the companies have entered into
Posted on 2/25/21
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
STAMFORD, Conn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe . . .
Posted on 2/25/21
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter and year ended December . . .
Posted on 2/25/21
There's More to Merck's New 'Bean Counter' CEO Than First Appears
There's going to be a change in leadership at Merck(NYSE:MRK) with CEO Ken Frazier retiring as of June 30 and Robert Davis, who currently serves as . . .
Posted on 2/25/21
Pfizer Has Gotten Better at Developing Drugs. Here's Why
Pfizer(NYSE:PFE) presented some interesting statistics during its fourth-quarter earnings report that showed the company has increased its success rate for getting drugs through clinical development. In . . .
Posted on 2/25/21
Here's Why Bristol Myers Squibb Is Making A Mistake With Its Cash
Bristol Myers Squibb (NYSE:BMY) is generating plenty of cash flow and recently used $4 billion of its nest egg to pay down debt. In this video . . .
Posted on 2/24/21
Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2020 Results
Tabula Rasa HealthCare, Inc. (Nasdaq: TRHC), a healthcare technology company advancing the safe use of medications, today reported financial results for the fourth quarter and full . . .
Posted on 2/24/21
DLA Piper Advises Truvian Sciences in Oversubscribed $105 Million Series C
DLA Piper represented Truvian Sciences in its recent oversubscribed US$105 million Series C financing. The round was led by TYH Ventures, Glen Tullman of 7wireVentures and . . .
Posted on 2/24/21
22nd Century Group Provides Business Update Letter from CEO
WILLIAMSVILLE, N.Y., Feb. 24, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm . . .
Posted on 2/23/21
Koffie Labs Raises $4.5 Million
Koffie Labs, an insurtech focused on reinventing the trucking and transportation markets, today announced it has raised $4.5m in venture financing. Anthemis Group and Lerer Hippeau . . .
Posted on 2/22/21
Oscar Health Launch of IPO
Oscar Health, Inc. today announced the launch of its initial public offering of 31,000,000 shares of its Class A common stock. The offering consists of 30,350,920 shares . . .
Posted on 2/22/21
Applied Therapeutics Closes of Public Offering
NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated . . .
Posted on 2/22/21
Pfizer and BioNTech Coronavirus Vaccine Effective After 1 Dose, Can Last 2 Weeks in Standard Freezer, Separate Research Shows
On Friday, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) announced that they have submitted new data about their BNT162b2 vaccine to the Food and Drug Administration. With this . . .
Posted on 2/22/21
Will AstraZeneca's Pain Be Johnson & Johnson's Gain?
South Africa recently placed AstraZeneca's (NASDAQ:AZN) COVID-19 vaccine on hold. However, the country began vaccinating some individuals with Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine, even though . . .
New York
